ANPP recalls one batch of Arovan atorvastatin over quality defect
The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Arovan atorvastatin 10 mg tablets after identifying a quality defect; the affected…
Read the notice →Home / Alerts & Recalls
Recalls, falsified medicines, agency alerts and import holds — with batch numbers.
Showing 1–11 of 11 notices
The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Arovan atorvastatin 10 mg tablets after identifying a quality defect; the affected…
Read the notice →The Agence Nationale des Produits Pharmaceutiques has imposed a quarantine on eight batches of Clamoxyl 1g amoxicillin tablets after identifying a quality defect.
Read the notice →The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Isotanak ginkgo biloba oral solution after identifying a quality defect; the affected…
Read the notice →The Agence Nationale des Produits Pharmaceutiques has ordered a batch recall of Ferolam sodium feredetate syrup after identifying a quality defect; the affected batch…
Read the notice →The Agence Nationale des Produits Pharmaceutiques has ordered a voluntary batch recall and quarantine of GANT H sterile latex surgical gloves, size 6.5, after…
Read the notice →Nigeria's National Agency for Food and Drug Administration and Control has prohibited pesticides containing paraquat, chlorpyrifos and atrazine after completing a phased regulatory review,…
Read the notice →
The Pharmacy and Poisons Board has identified two falsified batches of Lucentis (ranibizumab) 0.3mg injection in the Kenyan market, with one arrest made and…
Read the notice →Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the market to four batches of medicines…
Read the notice →
SPBC urges Pakistan's pharmaceutical industry to address alleged brand falsification in Somalia, warning that the conduct of individual traders could undermine confidence in legitimate…
Read the notice →Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has warned that suspected falsified products imitating Forxiga (dapagliflozin)…
Read the notice →The order covers YENISOM Healthcare's entire range rather than named batches, and the agency says the ground is procedural: required entry testing was not…
Read the notice →Independent pharmaceutical news and regulatory intelligence covering Africa.